U.S. federal trademark · Serial No. 78676454 · Reg. No. 3303814
Pharmaceuticals for the Treatment of Acute Exposure to Blood Containing HBsAg, Perinatal Exposure of Infants Born to HBsAg-Positive Mothers, Sexual Exposure to HBsAg Positive Persons and Household Exposure to Persons With Acute HBV Infection
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.